Winkelmand
Farmacie, Life sciences & BioTech
Dit zijn de voorlopers in innovatie in de categorie Farmacie, Life sciences & BioTech
| Rank | Bedrijf | ||
|---|---|---|---|
| 1 | MSD | ||
| 2 | Pfizer | ||
| 3 | GlaxoSmithKline (GSK) | ||
| 4 | Abbott | ||
| 5 | AstraZeneca | ||
| 6 | Bayer | ||
| 7 | Johnson & Johnson Innovative Medicine | ||
| Strategie | Score | ||
| 1 | Abbott | ||
| 2 | MSD | ||
| 3 | Bayer | ||
| 4 | Johnson & Johnson Innovative Medicine | ||
| 5 | AstraZeneca | ||
| 6 | Pfizer | ||
| 7 | GlaxoSmithKline (GSK) | ||
| Talent | Score | ||
| 1 | Pfizer | ||
| 2 | AstraZeneca | ||
| 3 | GlaxoSmithKline (GSK) | ||
| 4 | Abbott | ||
| 5 | MSD | ||
| 6 | Bayer | ||
| 7 | Johnson & Johnson Innovative Medicine | ||
| Marktimpact | Score | ||
| 1 | GlaxoSmithKline (GSK) | ||
| 2 | MSD | ||
| 3 | Bayer | ||
| 4 | Pfizer | ||
| 5 | AstraZeneca | ||
| 6 | Abbott | ||
| 7 | Johnson & Johnson Innovative Medicine | ||
| Maatschappelijke impact | Score | ||
| 1 | Pfizer | ||
| 2 | MSD | ||
| 3 | Johnson & Johnson Innovative Medicine | ||
| 4 | GlaxoSmithKline (GSK) | ||
| 5 | Abbott | ||
| 6 | AstraZeneca | ||
| 7 | Bayer | ||